期刊
FUTURE ONCOLOGY
卷 18, 期 20, 页码 2489-2498出版社
FUTURE MEDICINE LTD
DOI: 10.2217/fon-2022-0155
关键词
bioimpedance analysis; breast cancer; hounsfield unit; metabolic syndrome; sarcopenic obesity
类别
This study investigated the clinical and body composition data of early-stage breast cancer patients and found that sarcopenic obesity is important in malignancy. By analyzing the components of metabolic syndrome and muscle radiation attenuation, it was found that the Hounsfield unit average value can predict the presence of sarcopenic obesity in early-stage breast cancer patients with metabolic syndrome.
Aim: The importance of sarcopenic obesity (SO) in malignancy has recently been recognized. The authors aimed to investigate the clinical and body composition data of early-stage breast cancer (BC) patients by focusing on the components of metabolic syndrome (MetS) and SO. Methods: In this cross-sectional study with early-stage BC patients, the clinical and laboratory results were evaluated for diagnosing MetS. Bioimpedance analysis and muscle radiation attenuation (Hounsfield unit average calculation [HUAC]) using acquired computed tomography images were used to assess SO. Results: The age at diagnosis, BMI, visceral fat ratio, hemoglobin A1c and carcinoembryonic antigen levels in patients with MetS were significantly higher (p < 0.05). A cutoff value of 39.4 Hounsfield units was significantly related to MetS with 76.5% sensitivity and 62% specificity. The mean HUAC in patients with MetS (36.9) was significantly lower than in those without MetS (41.4; p = 0.017). Conclusion: HUAC value predicted SO in early-stage BC patients with MetS.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据